BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 12218209)

  • 1. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
    Mikami Y; Hata S; Kiyokawa T; Manabe T
    Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
    Soslow RA; Ali A; Oliva E
    Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
    Chu PG; Arber DA; Weiss LM; Chang KL
    Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
    Gallardo A; Prat J
    Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correspondence re: Mikami Y, Hata S, Kiyokawa T, Manabe T. Expression of CD10 in malignant mullerian mixed tumors and adenosarcomas: an immunohistochemical study. Mod pathol 2002;15:923-30.
    Zamecnik M
    Mod Pathol; 2003 Jun; 16(6):618-9; author reply 619. PubMed ID: 12808069
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of myocardin in the classification of mesenchymal tumors of the uterus.
    Liang J; Wu L; Xiao H; Li N; Wang H; Cheng C; Bai R; Zhao Y; Zheng H
    Int J Gynecol Pathol; 2010 Jan; 29(1):55-62. PubMed ID: 19952936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mullerian adenosarcoma of the female genital tract.
    McCluggage WG
    Adv Anat Pathol; 2010 Mar; 17(2):122-9. PubMed ID: 20179434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors.
    Buza N; Tavassoli FA
    Int J Gynecol Pathol; 2009 Nov; 28(6):514-21. PubMed ID: 19851197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases.
    Abeler VM; Nenodovic M
    Int J Gynecol Pathol; 2011 May; 30(3):236-43. PubMed ID: 21464730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma.
    Van Mieghem T; Abeler VM; Moerman P; Verbist L; Vergote I; Amant F
    Gynecol Oncol; 2005 Nov; 99(2):493-6. PubMed ID: 16051333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant mixed mullerian tumor in a rabbit (Oryctolagus cuniculus): case report with immunohistochemistry.
    Goto M; Nomura Y; Une Y; Goldschmidt MH
    Vet Pathol; 2006 Jul; 43(4):560-4. PubMed ID: 16847001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERBB-2 gene overexpression and amplification in uterine sarcomas.
    Amant F; Vloeberghs V; Woestenborghs H; Debiec-Rychter M; Verbist L; Moerman P; Vergote I
    Gynecol Oncol; 2004 Dec; 95(3):583-7. PubMed ID: 15581967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma.
    Yoon JY; de Kock L; Stewart CJR; McCluggage WG; Foulkes WD; Clarke BA; Rouzbahman M
    Cancer Treat Res Commun; 2021; 27():100363. PubMed ID: 33838572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
    Costa MJ; Khan R; Judd R
    Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
    McCluggage WG; Sumathi VP; Maxwell P
    Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant müllerian mixed tumor (carcinosarcoma) of the fallopian tube: an immunohistochemical study of neoplastic cells.
    Kuroda N; Moriki T; Oguri H; Maeda N; Toi M; Miyazaki E; Hiroi M; Fukaya T; Enzan H
    APMIS; 2005 Sep; 113(9):643-6. PubMed ID: 16218942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary peritoneal malignant mixed Müllerian tumors. A clinicopathologic, immunohistochemical, and genetic study.
    Shen DH; Khoo US; Xue WC; Ngan HY; Wang JL; Liu VW; Chan YK; Cheung AN
    Cancer; 2001 Mar; 91(5):1052-60. PubMed ID: 11251959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
    Jeffers MD; Richmond JA; Macaulay EM
    Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
    Clement PB; Zubovits JT; Young RH; Scully RE
    Int J Gynecol Pathol; 1998 Jul; 17(3):211-22. PubMed ID: 9656116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.